Y la verdad es q uno ve el perfil q esta haciendo en la grafica diaria y vamos una linea progresiva bonita. Es lo q hay ahora pienso en nvax y gnca como decia ayer. Hace unas semanas sonaba con los 14 de tgtx y me quede en 13,32 jeje muy contento,practicamente segun lo soñado.
No les va a hacer falta...tienen hasta Q3 y antes llegará partnership o Buyout. Jeff Baxter CEO ayer en la conferencia que publicaron resultados mejores que Engerix-B lider mercado. GSK tiene una presentación 14 enero JPM healthcare conference (por si anuncian algo)
Te las transcribo literales del webcast.
"We are in a number of discussions which are obviously CBA bound with a number of potential partners from global pharma companies, to regional potential partners, to more straight forward commercialization partners in the markets.
We will commercialize Sci-B-Vac with a partner, we will not be doing it ourselves, I have said this publicly many times before, we will not be recruiting 100 people and suffering the financial burden of 50M $ in the commercial ramp up.
We will do it in a creative way with a partner from those range of people that I spoke earlier which means that we can launch this product in a highly cost effective but most importantly a really commercial effective way such that we can hit the ground running".
Seroprotection 18-45 Phase 3 CONSTANT Sci-B-Vac vs Engerix-B
Vaya,habia dejado una orden de 6000 a 3,90 y no ha entrado...ha pegado un bajon a 3,91 segun veo pero 3,90 no. Normalmente cdo quiere tirar pa bajo suele entrar a toda leche. A ver como evoluciona.
